Literature DB >> 15723655

Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Yoko Karube1, Hisaaki Tanaka, Hirotaka Osada, Shuta Tomida, Yoshio Tatematsu, Kiyoshi Yanagisawa, Yasushi Yatabe, Junichi Takamizawa, Shinichiro Miyoshi, Tetsuya Mitsudomi, Takashi Takahashi.   

Abstract

Emerging evidence suggests that microRNA, which are well-conserved, abundant and small regulatory RNA, may be involved in the pathogenesis of human cancers. We recently reported that expression of let-7 was frequently reduced in lung cancers, and that reduced let-7 expression was significantly associated with shorter patient survival. Two members of the double-stranded RNA-specific endonuclease family, Dicer and Drosha, convert precursor forms of microRNA into their mature forms using a stepwise process. In the present study, we examined expression levels of these genes in 67 non-small cell lung cancer cases, and found for the first time that Dicer expression levels were reduced in a fraction of lung cancers with a significant prognostic impact on the survival of surgically treated cases. It should be noted that multivariate COX regression analysis showed that the prognostic impact of Dicer (P=0.001) appears to be independent of disease stage (P=0.001), while logistic regression analysis demonstrated that the higher incidence of reduced Dicer expression in poorly differentiated tumors remained significant even after correction for other parameters (P=0.02). Given the fundamental and multiple biological roles of Dicer in various cellular processes, our results suggest the involvement of reduced Dicer expression in the development of lung cancers, thus warranting further investigations of the underlying mechanisms, which can be expected to enhance understanding of the molecular pathogenesis of this fatal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723655     DOI: 10.1111/j.1349-7006.2005.00015.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  240 in total

Review 1.  Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.

Authors:  Ying Zi; Zhongmin Yin; Weizhong Xiao; Xinwei Liu; Zhixiang Gao; Li Jiao; Lianfu Deng
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

2.  miRNAs in human cancer.

Authors:  Xiaomin Zhong; George Coukos; Lin Zhang
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Mechanisms of control of microRNA biogenesis.

Authors:  Brandi N Davis-Dusenbery; Akiko Hata
Journal:  J Biochem       Date:  2010-09-09       Impact factor: 3.387

4.  Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.

Authors:  Andrew Jakymiw; Rushi S Patel; Natasha Deming; Indraneel Bhattacharyya; Priya Shah; Richard J Lamont; Carol M Stewart; Donald M Cohen; Edward K L Chan
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

5.  Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway.

Authors:  Qunfang Li; Michael A Tainsky
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

Review 6.  Causes and consequences of microRNA dysregulation.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

7.  Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

Authors:  Giovanni Blandino; Mariacristina Valerio; Mario Cioce; Federica Mori; Luca Casadei; Claudio Pulito; Andrea Sacconi; Francesca Biagioni; Giancarlo Cortese; Sergio Galanti; Cesare Manetti; Gennaro Citro; Paola Muti; Sabrina Strano
Journal:  Nat Commun       Date:  2012-05-29       Impact factor: 14.919

8.  Dysregulation of microRNA biosynthesis enzyme Dicer plays an important role in gastric cancer progression.

Authors:  Jin Zhang; Xin-Hua Zhang; Cai-Xia Wang; Biao Liu; Xiang-Shan Fan; Juan-Juan Wen; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 9.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

10.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Marie Acquafondata; Teresa McHale; Robert W Sobol; Rajiv Dhir
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.